Jay Reinstein News Today

Long before people develop dementia, they often begin falling behind on their mortgages, credit card bills and other financial obligations, new research shows.

UNC researchers are studying how amyloid plaque forms in the brain in hopes of developing breakthrough treatments for Alzheimer's disease.

/PRNewswire/ -- A new video series from the Alliance for Aging Research—Expert Conversations on Neuropsychiatric Symptoms of Alzheimers—is now available to...

New videos featuring expert conversations aim to shake the stigmaWASHINGTON, July 20, 2023 /PRNewswire/ -- A new video series from the Alliance fo...

Jay Reinstein, who has Alzheimer's disease, sits on a bed after undergoing a PET scan at MedStar Georgetown University Hospital on June 20, 2023 in

Two new drugs are exciting patients and doctors fighting Alzheimer's disease, along with a new diagnosis strategy.

Jay Reinstein, who suffers from Alzheimer's, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, DC on…

The FDA granted approval to Leqembi on Thursday afternoon, a drug that has been shown to slow cognitive decline in early-stage Alzheimer's patients.

A drug called Leqembi, which modestly slows progression of the disease, is expected soon to receive full approval from federal regulators.

Members of the organization Voices of Alzheimer’s want Medicare to cover a drug that slows down the progression of early Alzheimer’s.